Evidence map›Paper›PMID 12930375›Full record

ArticleClinical and experimental immunology2003

T cell receptor VB repertoire diversity in patients with immune thrombocytopenia following splenectomy.

P F Fogarty, M E Rick, W Zeng, A M Risitano, C E Dunbar, J B Bussel

Open access · greenAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Pathogenesis of refractory ITP: Overview.British journal of haematology · 2023
    Review
  5. How we treat primary immune thrombocytopenia in adults.Journal of hematology & oncology · 2023
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Pathophysiology and therapeutic options in primary immune thrombocytopenia.Blood transfusion = Trasfusione del sangue · 2011
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

P F FogartyHematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1652, USA.
M E Rick
W Zeng
A M Risitano
C E Dunbar
J B Bussel
National Heart Lung and Blood Institute · USNational Institutes of Health Clinical Center · USCornell University · USNational Institutes of Health · US

Funding

Optimization of gene transfer safety and efficacy focusing on the NHP modelZIAHL002339 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI DUNBAR, CYNTHIA E · 2009 to 2025
$26.8M
PRECLINICAL AND CLINICAL GENE TRANSFER TO HUMAN HEMATOPOIETIC STEM CELLSZ01HL002339 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI DUNBAR, CYNTHIA E · 1992 to 2008
$6.2M
6 · The paper itself

Abstract

In recent years, a pathophysiological role for T cells in immune thrombocytopenia (ITP) has been established. We applied cDNA size distribution analysis of the T cell receptor (TCR) beta-variable (VB) complementarity-determining region 3 (CDR3) in order to investigate T cell repertoire diversity among immune thrombocytopenia patients who had either responded or not responded to splenectomy, and compared them to normal controls. ITP patients who had had a durable platelet response to splenectomy showed a mean 2.8 +/- 2.1 abnormal CDR3 size patterns per patient, similar to healthy volunteers (2.9 +/- 2.0 abnormal CDR3 size patterns). In contrast, patients unresponsive to splenectomy demonstrated evidence of significantly more clonal T cell expansions than patients who had responded to splenectomy or controls (11.3 +/- 3.3 abnormal CDR3 size patterns per patient; P < 0.001). Of the VB subfamilies analysed, VB3 and VB15 correlated with response or non-response to splenectomy, each demonstrating oligoclonality in non-responding patients (P < 0.05). These findings suggest that removal of the spleen may lead directly or indirectly to reductions in T cell clonal expansions in responders, or that the extent of T cell clonality impacts responsiveness to splenectomy in patients with ITP.

Indexed as

Genes, T-Cell Receptor betaAdultAnalysis of VarianceCase-Control StudiesFemaleGenetic VariationHumansImmunoglobulin Variable RegionMaleMiddle AgedReceptor-CD3 Complex, Antigen, T-CellReverse Transcriptase Polymerase Chain ReactionRNASplenectomyThrombocytopeniaTreatment FailureImmunoglobulin Variable RegionReceptor-CD3 Complex, Antigen, T-CellRNA

Identifiers

PMID12930375
PMCPMC1808786
OpenAlexW2044592287

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.